by Dr. Geoffrey Sher | Dec 11, 2018 | Cost of IVF Treatment
Given rapidly changing practices in the IVF arena, it is becoming increasingly implausible to reliably interpret current national reports expressing IVF outcome statistics as birth rate per initiated treatment cycle, per egg retrieval procedure or per embryo transfer...
by Dr. Geoffrey Sher | Dec 10, 2018 | Case Studies, Controversial Post, Failed IVF, Infertility, IVF
Given rapidly changing practices in the IVF arena, it is becoming increasingly implausible to reliably interpret current national reports expressing IVF outcome statistics as birth rate per initiated treatment cycle, per egg retrieval procedure or per embryo transfer...
by Dr. Geoffrey Sher | Dec 3, 2018 | gender identification testing, Genetically Testing IVF Embryos, IVF, IVF Genetic Screening
Preimplantation genetic testing (PGT) involves testing pre-implantation embryos for chromosomal numerical abnormalities (aneuploidy). Preimplantation genetic diagnosis (PGD) involves genetic testing of embryos for specific genetic conditions. The objective of both PGT...
by Dr. Geoffrey Sher | Dec 3, 2018 | Immunologic Implantation Dysfunction
In the United States, effective treatment of NK/CTL activation associated with either alloimmune or autoimmune implantation dysfunction requires the administration of primarily Intralipid (IL). Such treatment is much more likely to be successful in the case of`...
by Dr. Geoffrey Sher | Nov 23, 2018 | Uncategorized
In the United States, effective treatment of natural killer cell /cytotoxic lymphocyte (NK/CTL)-activation associated with either alloimmune or autoimmune implantation dysfunction requires the administration of primarily Intralipid (IL) or Intravenous gamma-globulin...